Skip directly to content

Research

Pfizer is a significant contributor to the conduct of clinical trials in New Zealand. Clinical trials are human tests that help doctors understand if a new medicine is more effective or safer than existing medicines or treatments, and to determine the appropriate dosage of the new medicine.

Results from clinical trials can lead to the development of medicines that can prevent death and also improve the lives of people suffering from a diverse range of challenging medical conditions.

Most recently Pfizer clinical trials have focussed on the following areas:

  • Cardiovascular
  • Inflammation
  • Gastrointestinal
  • Metabolic diseases
  • Haematology
  • Oncology
  • Pain

See also Centres for Therapeutic Innovation and Clinical Trials pages.

Snapshot
Pfizer NZ Research